51 related articles for article (PubMed ID: 11728980)
1. Endothelial chylomicron binding is altered by interaction with high-density lipoprotein in Heymann's nephritis.
Shearer GC; Couser WG; Kaysen GA
Am J Kidney Dis; 2001 Dec; 38(6):1385-9. PubMed ID: 11728980
[TBL] [Abstract][Full Text] [Related]
2. Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome.
Shearer GC; Stevenson FT; Atkinson DN; Jones H; Staprans I; Kaysen GA
Kidney Int; 2001 Jan; 59(1):179-89. PubMed ID: 11135070
[TBL] [Abstract][Full Text] [Related]
3. Effect of plasma oncotic pressure on apolipoprotein levels in rats with Heymann nephritis.
Kaysen GA; Jones H; Joles JA; van Tol A
Miner Electrolyte Metab; 1996; 22(1-3):31-8. PubMed ID: 8676821
[TBL] [Abstract][Full Text] [Related]
4. Nephrotic livers secrete normal VLDL that acquire structural and functional defects following interaction with HDL.
Shearer GC; Couser WG; Kaysen GA
Kidney Int; 2004 Jan; 65(1):228-37. PubMed ID: 14675054
[TBL] [Abstract][Full Text] [Related]
5. Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis.
Marsh JB; Sparks CE
J Clin Invest; 1979 Nov; 64(5):1229-37. PubMed ID: 227928
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A-I complexed with phospholipid promotes hepatic lipoprotein and apolipoprotein secretion in the perfused hamster liver.
Song W; Chen J; Redinger RN
J Investig Med; 1998 Dec; 46(9):460-9. PubMed ID: 9861782
[TBL] [Abstract][Full Text] [Related]
7. Graded effects of proteinuria on HDL structure in nephrotic rats.
Shearer GC; Newman JW; Hammock BD; Kaysen GA
J Am Soc Nephrol; 2005 May; 16(5):1309-19. PubMed ID: 15788471
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein AI levels are increased in part as a consequence of reduced catabolism in nephrotic rats.
Kaysen GA; Hoye E; Jones H
Am J Physiol; 1995 Mar; 268(3 Pt 2):F532-40. PubMed ID: 7900854
[TBL] [Abstract][Full Text] [Related]
9. Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein.
Sehayek E; Lewin-Velvert U; Chajek-Shaul T; Eisenberg S
J Clin Invest; 1991 Aug; 88(2):553-60. PubMed ID: 1864965
[TBL] [Abstract][Full Text] [Related]
10. Metabolic fate of chylomicron phospholipids and apoproteins in the rat.
Tall AR; Green PH; Glickman RM; Riley JW
J Clin Invest; 1979 Oct; 64(4):977-89. PubMed ID: 225354
[TBL] [Abstract][Full Text] [Related]
11. Serum lipoproteins and apolipoproteins in rats with streptozotocin-induced diabetes.
Bar-On H; Roheim PS; Eder HA
J Clin Invest; 1976 Mar; 57(3):714-21. PubMed ID: 175093
[TBL] [Abstract][Full Text] [Related]
12. [Chylomicron and VLDL metabolism in daunomycin-induced nephrotic rats].
Gomikawa S; Hiraoka K; Yamanashi T; Mori H; Fujita Y; Takamitsu Y
Nihon Jinzo Gakkai Shi; 1995 Jul; 37(7):366-72. PubMed ID: 7637207
[TBL] [Abstract][Full Text] [Related]
13. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
Venkatesan N; Devaraj SN; Devaraj H
Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
[TBL] [Abstract][Full Text] [Related]
14. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
Pérez-Méndez O; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
Clin Chim Acta; 2006 Jun; 368(1-2):149-54. PubMed ID: 16487502
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein gene expression in analbuminemic rats and in rats with Heymann nephritis.
Sun X; Jones H; Joles JA; van Tol A; Kaysen GA
Am J Physiol; 1992 May; 262(5 Pt 2):F755-61. PubMed ID: 1590420
[TBL] [Abstract][Full Text] [Related]
16. Effect of oncotic pressure on apolipoprotein A-I metabolism in the rat.
Kaysen GA; Hoye E; Jones H; van Tol A; Joles JA
Am J Kidney Dis; 1995 Jul; 26(1):178-86. PubMed ID: 7611250
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.
Kerjaschki D; Exner M; Ullrich R; Susani M; Curtiss LK; Witztum JL; Farquhar MG; Orlando RA
J Clin Invest; 1997 Nov; 100(9):2303-9. PubMed ID: 9410908
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the metabolic behavior of rat apolipoproteins A-I and A-IV, isolated from both lymph chylomicrons and serum high density lipoproteins.
Dallinga-Thie GM; van't Hooft FM; van Tol A
Int J Biochem; 1986; 18(4):383-8. PubMed ID: 3086149
[TBL] [Abstract][Full Text] [Related]
19. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.
Riwanto M; Rohrer L; Roschitzki B; Besler C; Mocharla P; Mueller M; Perisa D; Heinrich K; Altwegg L; von Eckardstein A; Lüscher TF; Landmesser U
Circulation; 2013 Feb; 127(8):891-904. PubMed ID: 23349247
[TBL] [Abstract][Full Text] [Related]
20. Defective lipolysis persists in hearts of rats with heymann nephritis in the absence of nephrotic plasma.
Kaysen GA; Pan XM; Couser WG; Staprans I
Am J Kidney Dis; 1993 Jul; 22(1):128-34. PubMed ID: 8322775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
